Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

87 ArticlesPharmaceuticals

7 / 9

Lupin’s tussle with the FDA and Investors – a lesson for the Pharma Industry

Lupin was and is all over the news. Why? Yesterday IIFL published an article in relation to the FDA’s inspection of Lupin’s Mandideep facility based on a ...
Lupin-Share-Price.png

Cadila Healthcare Gets Import Alert by WHO for Bad Manufacturing Practices

Cadila Healthcare was slapped with a World Health Organization (WHO) Notice of Concern (NOC) on the 29-Jan-15 (Note date: It’s three months ago) for the ...
Cadila-Healthcare-WHO-Letter.png

Marksans Pharma – Discovery of serious GMP non-compliance

Marksans Pharma has been in the news for 2 different events. We covered the latest event yesterday in our daily Deal Flow report “Vanguard ...

Smallcap World Fund buys a huge stake in Page Industries and Vanguard International buys into Marksans Pharma

Deal flow for today shows FII leading the deal table. 2 US based funds Smallcap World Fund and Vanguard International Explorer Fund scored new deals worth ...

Emcure Pharmaceuticals – US FDA Warning, Health Ministry Ban Shows Chinks in Pharma

Emcure Pharmaceuticals (part of Emcure Group – Emcure USA, Gennova, Zuventus, Heritage and Tillomed Laboratories). The company is neither listed on the ...

Premium: US FDA Warning Letter to IPCA Laboratories for Ratlam facility, Pithampur facility and Piparia Silvassa facility

  On the 29-Jan-16 (Tuesday), the US FDA issued a Warning Letter to IPCA Laboratories.  The letter was in relation to the: Inspection performed during ...

Misleading Reporting: Indian Pharma Company APIs are NOT Banned in the US

Today Vidya Krishnan of the Hindu decided to write a story. This was a story that apparently caused some random panic among stocks of the pharma variety ...

Premium: US FDA Warning Letter to Cadila Healthcare for Moraiya formulation facility and Ahmedabad API facility (Zyfine)

On the 23-Dec-15 (Wednesday), the US FDA issued a Warning Letter to Cadila Healthcare. The letter was in relation to the inspection performed from ...

2015 in Review: Sector Moves Show Pharma Best, Metals Worst

As part of our special year-end piece, here is the performance of Sectoral Indices. Apologies as this is a little dated, but the numbers haven’t changed ...

Premium: US FDA Warning Letter to Sun Pharmaceutical Industries for Halol facility

  On the 17-Dec-15 (Thursday), the US FDA issued a Warning Letter to Sun Pharmaceuticals. The letter was in relation to the inspection performed from ...